A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study of Metformin for the Prevention of Progression of Monoclonal Gammopathy of Undetermined Significance and Smoldering Multiple Myeloma
NOT ENROLLING
Trial ID:
NCT04850846 Protocol # :
21-008
Phase
II
Disease Sites
Unknown Sites
Multiple Myeloma
Principal Investigator
Nadeem, Omar
Site Research Nurses
Brule, Maurice, N.
Davie, Christine, M.
Fleming, Norah, Michelle
Freeman, Stefani, Danielle
Gentile, Alissa
Ginter, Lindsey
Hixon, Nicole, R.
Houghton, Nicole
Kosinski, Michelle
Loeser, Wendy
Miles, Brandy
Piper, Audrey, L.
Quinn, Caroline
Ricciardi, Caroline
Trial Description
Call 877-DF-TRIAL (877-338-7425) to learn more about this clinical trial, protocol #21-008
21-008